
A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohn’s Disease
Keshav, Satish, Vaňásek, Tomáš, Niv, Yaron, Petryka, Robert, Howaldt, Stephanie, Bafutto, Mauro, Rácz, István, Hetzel, David, Nielsen, Ole Haagen, Vermeire, Séverine, Reinisch, Walter, Karlén, Per, ScVolume:
8
Langue:
english
Journal:
PLoS ONE
DOI:
10.1371/journal.pone.0060094
Date:
March, 2013
Fichier:
PDF, 645 KB
english, 2013